Neukio Biotherapeutics

Neukio Biotherapeutics focuses on development of next generation allogenic cell therapies via the iPSC-CAR-NK axis.

General Information
Company Name
Neukio Biotherapeutics
Founded Year
2021
Location (Offices)
China +1
Founders / Decision Makers
Number of Employees
14
Industries
Biotechnology
Funding Stage
Series A
Social Media

Neukio Biotherapeutics - Company Profile

Neukio Biotherapeutics is a China-based biotechnology startup that was founded in 2021. The company focuses on the development of next-generation allogenic cell therapies via the iPSC-CAR-NK axis, emphasizing innovative immuno-oncology products. Recently, on 02 September 2022, Neukio Biotherapeutics secured a significant $50.00M Series A investment from a group of prominent investors, including Lilly Asia Ventures, IDG Capital, Sherpa Venture Capital, CD Capital, Kuanyu Private Equity, and Yahui Precision Medicine Fund.

Taxonomy: cell therapy, allogenic, iPSC, CAR-NK, immuno-oncology, innovation, oncology, immune system, therapy development, biotherapeutics

Funding Rounds & Investors of Neukio Biotherapeutics (2)

View All
Funding Stage Amount No. Investors Investors Date
Series A $50.00M 6 Yahui Precision Medicine Fund, Sherpa Healthcare Partners 02 Sep 2022
Angel Round $40.00M 3 Sherpa Healthcare Partners 29 Jul 2021

Latest News of Neukio Biotherapeutics

View All

No recent news or press coverage available for Neukio Biotherapeutics.

Similar Companies to Neukio Biotherapeutics

View All
JancsiTech - Similar company to Neukio Biotherapeutics
JancsiTech JancsiTech is a company focusing on intelligent radiation therapy and navigation.
Central Alabama Radiation Oncology - Similar company to Neukio Biotherapeutics
Central Alabama Radiation Oncology Where Compassion Meets Precision
Astera Cancer Care - Similar company to Neukio Biotherapeutics
Astera Cancer Care Advancing treatment, Advancing life